Eli Lilly's Insulin Price Cap Deal Collapses After Cert. Denial

By Hailey Konnath · April 16, 2024, 11:08 PM EDT

Eli Lilly & Co. and insulin buyers have called off a proposed nationwide settlement that would've capped insulin prices and been worth up to $500 million over several years, a decision...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Case Information

Case Title

CHAIRES et al v. NOVO NORDISK INC. et al

Case Number

Court

New Jersey

Nature of Suit

Racketeer/Corrupt Organization

Date Filed

February 02, 2017

Recent Articles By Hailey

November 14, 2024
Ex-Ga. Rep. Doug Collins To Head Trump's Veterans Affairs
November 12, 2024
Trump Taps Elon Musk To Head New 'Gov't Efficiency' Dept.
November 04, 2024
Kroger, State AGs Finalize Sprawling $1.37B Opioid Deal
October 24, 2024
McDonald's Customers File First Suits Over E. Coli Outbreak
October 23, 2024
TriZetto Gets New Damages Trial After Ax Of $200M Awards
October 21, 2024
Google, Meta Want Out Of GoodRx Health Data Sharing Suit
October 18, 2024
HHS Slams Hackensack Meridian's Chevron-Inspired Suit
October 08, 2024
Cedars-Sinai OB-GYN Accused Of Abusing, Harassing Patients
October 08, 2024
Apple Loses Bid For Jury Trial In Masimo Trade Secrets Fight
October 07, 2024
Mednax Gets Final OK For $6M Data Breach Settlement